2025 Distinguished Scientist Award Dinner and Presentation

John Hood, PhD

Co-Founder, CEO and Chairman

Dr. Hood is Co-Founder, Chief Executive Officer (CEO) and Executive Chairman of Endeavor BioMedicines. A veteran of the California life sciences community, Dr. Hood has founded and led several successful biotechnology companies throughout his 20-year career. He previously served as the Founder and CEO of Impact Biomedicines (now owned by Bristol Myers Squibb), the company that developed fedratinib, which is now approved worldwide for the treatment of myelofibrosis. Dr. Hood began his career in 2001 as Director of Research at TargeGen, where he co-discovered fedratinib and led a team identifying small molecule therapeutics for the treatment of cancer and eye disease. He is an inventor on 100+ patents and the author of 50+ scientific articles. Dr. Hood earned his PhD in Medical Physiology and a Bachelor of Science in Biochemistry from Texas A&M University.

About the talk:

Development of ENV-101, a best-in-class hedgehog inhibitor that is first agent to show reversal of fibrotic disease in man

• 6:00 PM Social Hour, Cash bar
• 7:00 PM Dinner
• 8:00 PM Award lecture

1st course

• Baby mixed greens, grape tomatoes, shaved parmesan, sourdough croutons, balsamic vinaigrette, and ranch

2nd course (Preselect prior to event)

• 8oz. Prime Rib
• Creamy horseradish, au jus, buttermilk chive mashed Yukon golds, seasonal vegetables

Or

• Grilled Tofino River Salmon
• Saffron cream sauce, parmesan risotto, seasonal vegetables

Or

• Herb and Citrus Roasted Chicken Breast
• Parmesan Risotto, seasonal vegetables

OR

• Fettuccini Alfredo (Vegetarian option)

3rd course

• House Made Mocha Chocolate Mousse with Toffee

Host or Publisher San Diego American Chemical Society